Latest Stock Buy or Sell? Make More Informed Decisions!

It reports Monday. They've had a great quarter and the CEO has gotten control of things. It pays a 6.6% dividend plus actual growth.

It reports Monday. Has been strong despite the Fed's rate hikes.

It reports Monday. It grows by acquiring that could buy US Steel.

It reports Tuesday. It's the second-cheapest S&P stock that isn't a bank. Are buying back a monster amount of shares. Stay long.

It reports Tuesday. Has major upside. The CEO has steered a beautiful break up. GE is now GE AEROSPACE.

It reports Tuesday. It has rebounded well from bottoming after issuing a recall. Shares could stall here, unless they announce something big. A good stock.

This could be the start of a major run in the stock, and their rebound is real. He'd buy before and after their report on Tuesday.

It reports Tuesday. It's a beat-and-raise machine, driven by subscription revenues. Loves this stick revenue.

It reports Tuesday. The last quarter has seen only bad news, but maybe Musk can pull a rabbit out of this hat and it better not be self-driving cars. There's a lot on the line for Tesla. He give Musk the benefit of the doubt.

It reports Wednesday. Nothing but bad news lately. They must announce something new; it can't be business as usual, like announcing a succession plan.

 It reports Wednesday. They have a lot of levers to push. Zuckerberg doesn't have to pull a rabbit out of a hat, just talking about earnings and forecasts. Wait. Their quarter could be like Netflix's where the quarter was good, but shares fell anyway.

It reports Wednesday. They keep putting up great numbers. Are offering generative AI to their customers and showing them how AI benefits their bottom lines.

It reports Wednesday. They've integrated robots into their operations, have a good point-of-sale and have the best menu with real value. They own their stores and it's not a franchise model. Average volumes per store keep rising.

It reports Thursday. Wait till the conference call before pulling the trigger. Also, shares have been on a scorching run leading up to earnings and may need a breather.

It reports Thursday. He expects them to announce new drug applications, the anti-cancer portfolio and their acquisitions.